Acyclovir /00587301/


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 47.3%
Diffuse Large B-cell Lymphoma 20.3%
Infection Prophylaxis 8.1%
Prophylaxis Against Graft Versus Host Disease 5.4%
Varicella Virus Test Positive 5.4%
Hiv Infection 4.1%
Antiviral Prophylaxis 2.7%
Herpes Zoster 2.0%
Hypertension 1.4%
Immunosuppression 1.4%
Multiple Myeloma 1.4%
Renal Failure 0.7%
Drug-induced Liver Injury 33.3%
Pneumonia 25.0%
Renal Failure Acute 16.7%
Reticulocytopenia 8.3%
Urinary Incontinence 8.3%
Vertigo 8.3%
Concomitant
Product Used For Unknown Indication 63.2%
Prophylaxis 6.8%
Plasma Cell Myeloma 6.7%
Multiple Myeloma 4.2%
Nausea 2.1%
Prophylaxis Against Graft Versus Host Disease 1.9%
Pain 1.9%
Vomiting 1.4%
Infection Prophylaxis 1.2%
Chronic Lymphocytic Leukaemia 1.1%
Hiv Infection 1.1%
Pyrexia 1.1%
Anxiety 1.1%
Herpes Zoster 1.0%
Hypertension 1.0%
Stem Cell Transplant 0.9%
Antifungal Prophylaxis 0.9%
Premedication 0.8%
Cellulitis 0.8%
Constipation 0.8%
Drug Ineffective 14.9%
Human Herpesvirus 6 Infection 9.2%
Weight Decreased 8.0%
Thrombocytopenia 6.9%
Sepsis 5.7%
Toxicity To Various Agents 5.7%
Death 4.6%
Multi-organ Failure 4.6%
Neuropathy Peripheral 4.6%
Off Label Use 4.6%
Pyrexia 4.6%
Renal Failure 4.6%
Renal Tubular Necrosis 3.4%
Urinary Tract Infection 3.4%
Vomiting 3.4%
Adrenal Gland Cancer 2.3%
Bone Pain 2.3%
Delirium 2.3%
Drug Ineffective For Unapproved Indication 2.3%
Injection Site Pain 2.3%

Drug Data